학술논문
Overall Adverse Event Profile of Vadadustat for the Treatment of Anemia Associated With Chronic Kidney Disease in Phase 3 Trials.
Document Type
Article
Author
Source
American Journal of Nephrology; 2022, Vol. 53 Issue 10, p701-710, 10p
Subject
Language
ISSN
02508095
Abstract
Copyright of American Journal of Nephrology is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)